Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin on Bone Measures in Women with T2D
NCT06770894Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Sep 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), osteoporosis, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Started Sep 2019; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)osteoporosis
Beyond the preview
Go deeper on NCT06770894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06770894.